AnaptysBio Inc expected to post a loss of $1.59 a share - Earnings Preview

AnaptysBio

06/11/2024 14:19

* AnaptysBio Inc  ANAB.OQ   ANAB.O  is expected to show a
fall in
quarterly revenue when it reports  results  for the period
ending January 1 0001
    * The San Diego California-based  company is expected to
report a
7.2% decrease in revenue to $8.353 million from $9.01 million a
year ago, according to the mean estimate from 12 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for AnaptysBio Inc is for a
loss
of $1.59 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 5.6%
in the last three months. ​
    * Wall Street's median 12-month price target for AnaptysBio
Inc is
$48.50​, above​ its last closing price of $19.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -1.66       -1.65      -1.14     Beat    30.8
 Jun. 30 2024  -0.78       -0.99      -1.71     Missed  -72.9
 Mar. 31 2024  -1.56       -1.57      -1.64     Missed  -4.7​
 Dec. 31 2023  -1.62       -1.60      -1.59     Beat    0.7
 ​​Jan.        -1.80       -1.79      -1.41     Beat    21.4
 1 0001                                                 
 Jun. 30 2023  -1.83       -1.70      -1.50     Beat    11.6​
 Jan. 1 0001   -1.08       -1.05      -1.58     Missed  -50.8
 Dec. 31 2022  -0.96       -0.96      -0.93     Beat    2.8
 This summary was machine generated November 6 at 14:19 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)